Centro Respiratorio Quilmes - Buenos Aires
Centro Respiratorio Quilmes comienza en 1992. Se priorizó brindar una atención diferenciada en múltiples aspectos: Alta capacitación profesional, soporte tecnológico actualizado y atención personalizada. En 2005 se emprendió en la investigación clínica. A tal efecto se cuenta con todo lo necesario para cumplir con la exigencias regulatorias de la actividad y poder brindar las comodidades para el desarrollo y monitoreo de los protocolos.Hipolito Yrigoyen 856, Quilmes, Buenos Aires
Select an option
I am a doctor
I am a sponsor
Specializations
Asma
Bronquiectasia
EPOC
Infecciones por micobacterias no tuberculosas
Our team
Medical staff
Marcelo José Fernández
Marcelo Fernandez
Gimena De Antonio
Agustina Ramos
Barbara Cabral
Open studies
Pulmonary fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - Bristol-Myers SquibbSee more
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - Bristol-Myers SquibbSee more
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis - BEACON-IPF - Pliant Therapeutics, Inc.See more
Asthma
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma - INC 54707-208 - Incyte CorporationSee more
Chronic bronchitis
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) - PILASTER - Chiesi Farmaceutici S.p.A.See more
Chronic obstructive pulmonary disease
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) - PILASTER - Chiesi Farmaceutici S.p.A.See more
